CBRE vs PROF · P/E 43, rev $35.77B vs rev $10.7M
CBRE Group Inc Class A (CBRE) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. PROF currently screens at market cap $238.7M.
Not investment advice. Open the CBRE and PROF stock pages for the full models.
Not investment advice.